Mesoporous silicate nanoparticles/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering

Krishnakumar, 2017, Clinical application of bone morphogenetic proteins for bone healing: a systematic review, Int. Orthop., 1 Lad, 2013, Cancer after spinal fusion: the role of bone morphogenetic protein, Neurosurgery, 73, 440, 10.1227/NEU.0000000000000018 Gothard, 2014, Tissue engineered bone using select growth factors: a comprehensive review of animal studies and clinical translation studies in man, Eur. Cells Mater., 28, 166, 10.22203/eCM.v028a13 Biondi, 2008, Controlled drug delivery in tissue engineering, Adv. Drug Deliv. Rev., 60, 229, 10.1016/j.addr.2007.08.038 Bessa, 2008, Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery), J. Tissue Eng. Regen. Med., 2, 81, 10.1002/term.74 Burr, 2012, Bone remodelling in osteoarthritis, Nat. Rev. Rheumatol., 8, 665, 10.1038/nrrheum.2012.130 Schmidt-Bleek, 2015, Boon and bane of inflammation in bone tissue regeneration and its link with angiogenesis, Tissue Eng. Part B Rev., 21, 354, 10.1089/ten.teb.2014.0677 Kim, 2015, Dual-controlled release system of drugs for bone regeneration, Adv. Drug Deliv. Rev., 94, 28, 10.1016/j.addr.2015.06.003 Dimitriou, 2005, Current concepts of molecular aspects of bone healing, Injury, 36, 1392, 10.1016/j.injury.2005.07.019 Chen, 2010, Toward delivery of multiple growth factors in tissue engineering, Biomaterials, 31, 6279, 10.1016/j.biomaterials.2010.04.053 Holmes, 2005, The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease, Genome Biol., 6, 209, 10.1186/gb-2005-6-2-209 Marsell, 2011, The biology of fracture healing, Injury, 42, 551, 10.1016/j.injury.2011.03.031 Patel, 2008, Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model, Bone, 43, 931, 10.1016/j.bone.2008.06.019 Ramazanoglu, 2013, Bone response to biomimetic implants delivering BMP-2 and VEGF: an immunohistochemical study, J. Cranio-Maxillofac. Surg., 41, 826, 10.1016/j.jcms.2013.01.037 Young, 2009, Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model, Tissue Eng. Part A., 15, 2347, 10.1089/ten.tea.2008.0510 Hou, 2013, Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α, Diabetes Res. Clin. Pr., 101, 62, 10.1016/j.diabres.2013.04.012 Bao, 2009, The role of vascular endothelial growth factor in wound healing, J. Surg. Res., 153, 347, 10.1016/j.jss.2008.04.023 Maes, 2012, Hypoxia-driven pathways in bone development, regeneration and disease, Nat. Rev. Rheumatol., 8, 358, 10.1038/nrrheum.2012.36 Wang, 2007, The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development, J. Clin. Invest., 117, 1616, 10.1172/JCI31581 Wan, 2008, Activation of the hypoxia-inducible factor-1α pathway accelerates bone regeneration, Proc. Natl. Acad. Sci. U. S. A., 105, 686, 10.1073/pnas.0708474105 Yuan, 2014, The translation initiation factor eIF3i up-regulates vascular endothelial growth factor A, accelerates cell proliferation, and promotes angiogenesis in embryonic development and tumorigenesis, J. Biol. Chem., 289, 28310, 10.1074/jbc.M114.571356 Ceradini, 2005, Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue, Trends Cardiovas. Med., 15, 57, 10.1016/j.tcm.2005.02.002 Ceradini, 2004, Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1, Nat. Med., 10, 858, 10.1038/nm1075 Brittenham, 2011, Iron-chelating therapy for transfusional iron overload, New Engl. J. Med., 364, 146, 10.1056/NEJMct1004810 Olivieri, 1997, Iron-chelating therapy and the treatment of thalassemia, Blood, 89, 739, 10.1182/blood.V89.3.739 Guzey, 2014, The effects of Desferroxamine on bone and bone graft healing in critical-size bone defects, Plast. Reconstr. Surg., 134, 62, 10.1097/01.prs.0000455407.75412.cb Hallaway, 1989, Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers, Proc. Natl. Acad. Sci. U. S. A., 86, 10108, 10.1073/pnas.86.24.10108 Imran ul-haq, 2013, Design of long circulating nontoxic dendritic polymers for the removal of iron in vivo, ACS Nano, 7, 10704, 10.1021/nn4035074 Yao, 2016, Hypoxia-mimicking nanofibrous scaffolds promote endogenous bone regeneration, ACS Appl. Mater. Interfaces, 8, 32450, 10.1021/acsami.6b10538 Liu, 2009, Phase separation, pore structure, and properties of nanofibrous gelatin scaffolds, Biomaterials, 30, 4094, 10.1016/j.biomaterials.2009.04.024 Sun, 2013, Biomimetic engineering of nanofibrous gelatin scaffolds with noncollagenous proteins for enhanced bone regeneration, Tissue Eng. Part A., 19, 1754, 10.1089/ten.tea.2012.0567 Yao, 2017, BBP-functionalized biomimetic Nanofibrous scaffold can capture BMP2 and promote osteogenic differentiation, J. Mater. Chem. B, 5, 5195, 10.1039/C7TB00744B Vallet-Regí, 2007, Mesoporous materials for drug delivery, Angew. Chem. Int. Ed., 46, 7548, 10.1002/anie.200604488 Slowing, 2008, Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers, Adv. Drug Deliv. Rev., 60, 1278, 10.1016/j.addr.2008.03.012 Kwon, 2013, Silica-based mesoporous nanoparticles for controlled drug delivery, J. Tissue Eng., 4, 10.1177/2041731413503357 Mekaru, 2015, Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy, Adv. Drug Deliv. Rev., 95, 40, 10.1016/j.addr.2015.09.009 He, 2014, MSN anti-Cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition, Adv. Mater., 26, 391, 10.1002/adma.201303123 Baeza, 2015, Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery, Expert. Opin. Drug Del., 12, 319, 10.1517/17425247.2014.953051 Fu, 2013, The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes, Biomaterials, 34, 2565, 10.1016/j.biomaterials.2012.12.043 Zhou, 2015, BMP-2 derived peptide and dexamethasone incorporated mesoporous silica nanoparticles for enhanced osteogenic differentiation of bone mesenchymal stem cells, ACS Appl. Mater. Interfaces, 7, 15777, 10.1021/acsami.5b02636 Shi, 2016, Copper-doped mesoporous silica nanospheres, a promising immunomodulatory agent for inducing osteogenesis, Acta Biomater., 30, 334, 10.1016/j.actbio.2015.11.033 Shi, 2009, Novel mesoporous silica-based antibiotic releasing scaffold for bone repair, Acta Biomater., 5, 1697, 10.1016/j.actbio.2009.01.010 Shadjou, 2015, Bone tissue engineering using silica-based mesoporous nanobiomaterials: recent progress, Mater. Sci. Eng. C, 55, 401, 10.1016/j.msec.2015.05.027 Liu, 2009, Biomimetic nanofibrous gelatin/apatite composite scaffolds for bone tissue engineering, Biomaterials, 30, 2252, 10.1016/j.biomaterials.2008.12.068 Slowing, 2007, Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins, J. Am. Chem. Soc., 129, 8845, 10.1021/ja0719780 Jia, 2016, Deferoxamine released from poly (lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis, J. Biomed. Mater. Res. Part A., 104, 2515, 10.1002/jbm.a.35793 Sun, 2010, Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds, Biomaterials, 31, 1133, 10.1016/j.biomaterials.2009.10.030 Yao, 2017, Three dimensional electrospun PCL/PLA blend nanofibrous scaffolds with significantly improved stem cells osteogenic differentiation and cranial bone formation, Biomaterials, 115, 115, 10.1016/j.biomaterials.2016.11.018 Siavashani, 2016, Effect of amino-functionalization on insulin delivery and cell viability for two types of silica mesoporous structures, J. Mater. Sci., 51, 10897, 10.1007/s10853-016-0301-1 Natarajan, 2014, Mesoporous silica nanoparticles: importance of surface modifications and its role in drug delivery, RSC Adv., 4, 14328, 10.1039/c4ra00781f Qu, 2015, Silicon oxide based materials for controlled release in orthopedic procedures, Adv. Drug Deliv. Rev., 94, 96, 10.1016/j.addr.2015.05.015 Knežević, 2015, Large pore mesoporous silica nanomaterials for application in delivery of biomolecules, Nano, 7, 2199 Wu, 2010, Structure–property relationships of silk-modified mesoporous bioglass scaffolds, Biomaterials, 31, 3429, 10.1016/j.biomaterials.2010.01.061 Bhattacharyya, 2012, Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules, Acta Biomater., 8, 3429, 10.1016/j.actbio.2012.06.003 Feng, 2010, Novel antibacterial nanofibrous PLLA scaffolds, J. Control. Release, 146, 363, 10.1016/j.jconrel.2010.05.035 Donneys, 2013, Localized deferoxamine injection augments vascularity and improves bony union in pathologic fracture healing after radiotherapy, Bone, 52, 318, 10.1016/j.bone.2012.10.014 Shen, 2009, Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice, J. Orthop. Res., 27, 1298, 10.1002/jor.20886 Sharmin, 2017, Dual growth factor delivery from biofunctionalized allografts: sequential VEGF and BMP-2 release to stimulate allograft remodeling, J. Orthop. Res., 35, 1086, 10.1002/jor.23287 Zhang, 2011, The use of injectable sonication-induced silk hydrogel for VEGF 165 and BMP-2 delivery for elevation of the maxillary sinus floor, Biomaterials, 32, 9415, 10.1016/j.biomaterials.2011.08.047 Matsubara, 2012, Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis, Bone, 51, 168, 10.1016/j.bone.2012.02.017 Drager, 2015, Hypoxia signalling manipulation for bone regeneration, Expert Rev. Mol. Med., 17, 10.1017/erm.2015.4 Yang, 2011, J.Jian, S.B. Abramson, X.Huang, inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis, J. Bone Miner. Res., 26, 1188, 10.1002/jbmr.337 Stewart, 2011, Increasing vascularity to improve healing of a segmental defect of the rat femur, J. Orthop. Trauma, 25, 472, 10.1097/BOT.0b013e31822588d8